Literature DB >> 19416471

Endocytic regulation of notch signalling during development.

Maximilian Fürthauer1, Marcos González-Gaitán.   

Abstract

Delta/Notch signalling is of major importance for embryonic development and adult life. While endocytosis is often viewed as a way to down-regulate biological signals, ligand and receptor internalization are essential for Notch activation. The development of Drosophila mecanosensory bristles is a powerful model to study Delta/Notch signalling. Following the asymmetric division of bristle precursor cells, Delta ligands and Notch receptors traffic differently in the two daughter cells, leading to directional signal activation. Recent evidence suggests that in addition to differential ligand endocytosis after division, a subpopulation of multivesicular endosomes ensures the directional transport of Delta/Notch already during asymmetric cell division. Biochemical analysis suggests that different phases of endocytic Delta trafficking exert complementary but distinct actions required for ligand recycling, ligand/receptor interaction and ligand-mediated receptor activation, respectively. Finally, novel data suggest that different endosomal compartments may act as Delta/Notch signalling platforms. In this review, we discuss the implications of these novel findings for our cell biological understanding of Delta/Notch signalling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416471     DOI: 10.1111/j.1600-0854.2009.00914.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  31 in total

Review 1.  Notch ligand endocytosis: mechanistic basis of signaling activity.

Authors:  Abdiwahab A Musse; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Semin Cell Dev Biol       Date:  2012-01-24       Impact factor: 7.727

2.  Cis-activation in the Notch signaling pathway.

Authors:  Nagarajan Nandagopal; Leah A Santat; Michael B Elowitz
Journal:  Elife       Date:  2019-01-10       Impact factor: 8.140

3.  Regulation of Notch signaling and endocytosis by the Lgl neoplastic tumor suppressor.

Authors:  Marta Portela; Linda M Parsons; Nicola A Grzeschik; Helena E Richardson
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles.

Authors:  Radek Dobrowolski; Edward M De Robertis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

5.  Crumbs is required to achieve proper organ size control during Drosophila head development.

Authors:  Emily C N Richardson; Franck Pichaud
Journal:  Development       Date:  2010-02       Impact factor: 6.868

6.  The vacuolar ATPase is required for physiological as well as pathological activation of the Notch receptor.

Authors:  Thomas Vaccari; Serena Duchi; Katia Cortese; Carlo Tacchetti; David Bilder
Journal:  Development       Date:  2010-06       Impact factor: 6.868

7.  Optical tweezers studies on Notch: single-molecule interaction strength is independent of ligand endocytosis.

Authors:  Bhupinder Shergill; Laurence Meloty-Kapella; Abdiwahab A Musse; Gerry Weinmaster; Elliot Botvinick
Journal:  Dev Cell       Date:  2012-05-31       Impact factor: 12.270

8.  Structural requirements for PACSIN/Syndapin operation during zebrafish embryonic notochord development.

Authors:  Melissa A Edeling; Subramaniam Sanker; Takaki Shima; P K Umasankar; Stefan Höning; Hye Y Kim; Lance A Davidson; Simon C Watkins; Michael Tsang; David J Owen; Linton M Traub
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

Review 9.  Scratching the niche that controls Caenorhabditis elegans germline stem cells.

Authors:  Dana T Byrd; Judith Kimble
Journal:  Semin Cell Dev Biol       Date:  2009-09-16       Impact factor: 7.727

Review 10.  Endocytosis, asymmetric cell division, stem cells and cancer: unus pro omnibus, omnes pro uno.

Authors:  Maximilian Fürthauer; Marcos González-Gaitán
Journal:  Mol Oncol       Date:  2009-06-06       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.